DUPIXENT® (dupilumab) is the
FIRST-AND-ONLY
FDA APPROVED
EoE (eosinophilic
esophagitis)
TREATMENT OPTION.
DUPIXENT is a prescription
medicine used to treat adult and
pediatric patients aged 12 years
and older who weigh at least
88 lb (40 kg) with eosinophilic
esophagitis (EoE).
DUPIXENT was proven to
REDUCE DIFFICULTY
SWALLOWING
DISCOVER AN
EoE BREAKTHROUGH
TREATMENT